What Researchers Did
Researchers conducted a systematic review to identify and analyze studies that connect hyperbaric oxygen therapy (HBOT) with artificial intelligence (AI) and related technologies.
What They Found
The review identified 53 eligible studies, with over 30% of these published between 2022 and 2025. These studies illustrate four main application areas for AI in HBOT: optimizing treatment protocols, selecting patients using biomarkers, real-time adaptive control with biosensors, and predicting safety risks like oxygen toxicity and barotrauma.
What This Means for Canadian Patients
This research suggests that integrating AI could lead to more precise and personalized HBOT treatments in the future. Canadian patients might benefit from improved patient selection, optimized treatment plans, and enhanced safety monitoring, potentially leading to better outcomes for conditions like diabetic foot ulcers or radiation injuries.
Canadian Relevance
This study covers several Health Canada-recognized indications for HBOT, including decompression sickness, carbon monoxide poisoning, radiation-induced tissue injury, and diabetic foot ulcers. No direct Canadian connection or authors were identified.
Study Limitations
This systematic review highlights potential future applications of AI in HBOT but does not present new clinical trial data on patient outcomes from AI-guided HBOT.